Venous Thrombosis
Information
- Disease name
- Venous Thrombosis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT00005504 | Active, not recruiting | Epidemiology of Venous Thrombosis and Pulmonary Embolism | February 1998 | April 2030 | |
NCT03945045 | Active, not recruiting | N/A | A Study of the IJV or the SCV Approach for Ultrasound-guided Implantation of TIVAD | May 21, 2019 | January 2024 |
NCT04724460 | Active, not recruiting | Phase 4 | Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer | February 18, 2021 | December 31, 2024 |
NCT04349189 | Active, not recruiting | Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait | September 1, 2020 | October 15, 2026 | |
NCT00185952 | Completed | N/A | Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor. | November 2001 | August 2008 |
NCT00203580 | Completed | Phase 4 | Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study) | December 1994 | March 2002 |
NCT00203658 | Completed | Phase 4 | Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin | April 1997 | October 2000 |
NCT00211146 | Completed | Phase 3 | A Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Patients Undergoing Major Elective Spinal Surgery (SPINE Study) | April 1998 | May 2006 |
NCT00244270 | Completed | Phase 4 | Cystic Fibrosis and Totally Implantable Vascular Access Devices | December 2005 | March 2009 |
NCT00246025 | Completed | Phase 2 | A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery. | October 2005 | |
NCT00265993 | Completed | Phase 4 | Enoxaparin in Acute Venous Thromboembolic Disease | December 2004 | January 2009 |
NCT00306254 | Completed | Phase 2 | Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery | March 2006 | July 2007 |
NCT00322270 | Completed | Phase 3 | Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters | January 2006 | |
NCT00346424 | Completed | Phase 3 | Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters | September 2005 | December 2006 |
NCT00351663 | Completed | Phase 4 | The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients | February 2007 | September 2015 |
NCT00356759 | Completed | Phase 2 | Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients | December 2006 | February 2010 |
NCT00395265 | Completed | Evaluating the Relationship Between Blood Clotting Disorders, Inflammation, and Obesity in Individuals With Venous Disorders and Post-Thrombotic Syndrome | June 2006 | December 2011 | |
NCT00436787 | Completed | Phase 2 | Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers | February 2007 | December 2007 |
NCT00440193 | Completed | Phase 3 | Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study | March 2007 | April 2010 |
NCT00457002 | Completed | Phase 3 | Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness | June 2007 | May 2011 |
NCT00457158 | Completed | Phase 4 | PREPIC 2 : Prevention of Recurrent Pulmonary Embolism by Vena Cava Interruption | July 2006 | November 2012 |
NCT00535171 | Completed | Venous Thromboembolism Taskforce Audit Program | June 2007 | ||
NCT00554632 | Completed | N/A | Birth Control Pill vs Birth Control Patch Study | April 2003 | August 2005 |
NCT00585182 | Completed | Phase 4 | Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT | January 2007 | April 2008 |
NCT00621491 | Completed | N/A | Prevention of Venous Thrombosis After Permanent Transvenous Leads Implantation | February 2004 | July 2008 |
NCT00633893 | Completed | Phase 3 | Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism | May 2008 | August 2012 |
NCT00643201 | Completed | Phase 3 | Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism | July 2008 | March 2013 |
NCT00687882 | Completed | Phase 3 | Evaluation of the Duration of Therapy for Thrombosis in Children | March 2008 | February 15, 2022 |
NCT00728819 | Completed | N/A | Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered Catheters | August 2008 | August 2011 |
NCT00778336 | Completed | A Prospective Observational Registry of Peripheral Use of AngioJet Rheolytic Thrombectomy With Mid-Length Catheters | January 2007 | April 2010 | |
NCT00786422 | Completed | Phase 2 | Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer | May 2009 | June 2011 |
NCT00790335 | Completed | Phase 3 | Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis | November 2009 | January 2017 |
NCT05890924 | Completed | Intimate Partner Violence as a Risk Factor for Venous Thromboembolism in Women | January 1, 2023 | September 5, 2023 | |
NCT00005684 | Completed | Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis | March 1996 | January 2001 | |
NCT00097357 | Completed | Phase 2/Phase 3 | BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery | October 2004 | December 2005 |
NCT00170378 | Completed | Phase 4 | The Use of Low Molecular Weight Heparin in Traumatic Brain Injury | December 2002 | August 2005 |
NCT01662908 | Completed | Phase 2 | A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis | August 2012 | March 2014 |
NCT01684423 | Completed | Phase 2 | Oral Rivaroxaban in Children With Venous Thrombosis | February 19, 2013 | September 1, 2016 |
NCT01736826 | Completed | Free DNA and Nucleosome Concentrations in Pathological Pregnancies | June 2015 | December 17, 2018 | |
NCT01779648 | Completed | N/A | Comparison of Different Intermittent Pneumatic Compression Devices for Deep Vein Thrombosis | March 2012 | January 2013 |
NCT01805544 | Completed | Satisfaction/Quality of Life With Rivaroxaban in DVT (Deep Venous Thrombosis) Indication | May 2013 | June 2015 | |
NCT01855100 | Completed | Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT) | July 2013 | December 2014 | |
NCT01857050 | Completed | Assessment of International Normalized Ratio (INR) Prolongation in Patients Treated Simultaneously With Warfarin and Cephalosporins | April 2013 | January 2014 | |
NCT01862471 | Completed | N/A | Neuromuscular Electrical Stimulation Versus Intermittent Pneumatic Compression for Blood Flow | May 2013 | June 2013 |
NCT01886612 | Completed | N/A | A Comparison of Neuromuscular Electrical Stimulation and Intermittent Pneumatic Compression in Terms of Lower Limb Blood Flow | June 2013 | August 2013 |
NCT01894997 | Completed | N/A | A Comparison of the Effects of Neuromuscular Electrical Stimulation and Intermittent Pneumatic Compression on Blood Flow in the Lower Limb | January 2014 | April 2014 |
NCT01947959 | Completed | Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany) | December 22, 2011 | September 30, 2020 | |
NCT01947985 | Completed | Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands) | February 1, 2012 | September 30, 2020 | |
NCT01947998 | Completed | Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK) | December 22, 2011 | September 30, 2020 | |
NCT01999179 | Completed | N/A | Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis | June 2014 | April 26, 2022 |
NCT02064439 | Completed | Phase 3 | Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) | March 5, 2014 | November 4, 2016 |
NCT02065388 | Completed | Phase 3 | Pharmacogenetic Dosing of Warfarin | September 2009 | December 2013 |
NCT02161965 | Completed | Phase 4 | Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation | May 21, 2013 | February 16, 2018 |
NCT02247414 | Completed | Phase 4 | Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection | September 2014 | April 2018 |
NCT02258958 | Completed | Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung Resection | January 2014 | December 2014 | |
NCT02301793 | Completed | N/A | Educating Nurses About Venous Thromboembolism (VTE) Prevention | April 1, 2014 | March 31, 2015 |
NCT02335580 | Completed | Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis | December 2014 | December 2022 | |
NCT02468102 | Completed | Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden) | June 15, 2015 | September 30, 2020 | |
NCT02567903 | Completed | N/A | Tourniquet Study: A Clinical Trial Into the Effect of Tourniquet Use on the Coagulation System | September 2015 | June 2019 |
NCT02581176 | Completed | Phase 4 | Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study | April 2016 | May 2018 |
NCT02584842 | Completed | Rivaroxaban in Endovenous Laser Ablation With and Without Miniphlebectomy | January 2012 | December 2014 | |
NCT02600260 | Completed | N/A | Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial | December 1, 2014 | December 28, 2019 |
NCT02651909 | Completed | Utilization of TEG to Monitor Rivaroxaban Activity | April 2016 | November 4, 2019 | |
NCT02867163 | Completed | Tranexamic Acid and Blood Clots in Knee Surgery | May 16, 2017 | November 8, 2017 | |
NCT02892565 | Completed | N/A | Hypercoagulable Phenotype by Thrombinography (in Presence of C Protein Dynamic Inhibitory System) | September 2005 | December 2009 |
NCT03044574 | Completed | N/A | Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism | February 1, 2017 | December 31, 2018 |
NCT03317145 | Completed | N/A | Lower Limb Blood Flow Geko vs Foot Pump | July 24, 2013 | February 19, 2014 |
NCT03328624 | Completed | N/A | A Preliminary Clinical Usability Study for the Recovery Force DVT II Cuff | January 23, 2018 | April 25, 2018 |
NCT03505723 | Completed | Phase 3 | PeriOperative ISchemic Evaluation-3 Trial | June 27, 2018 | February 3, 2023 |
NCT03714048 | Completed | Blood Management During ECMO for Cardiac Support | July 1, 2019 | April 15, 2023 | |
NCT03895502 | Completed | Phase 4 | Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study | May 27, 2019 | August 31, 2023 |
NCT04339894 | Completed | Prospective Epidemiological Study of Upper Limb Venous Thrombosis | August 4, 2020 | January 12, 2023 | |
NCT04645550 | Completed | Phase 4 | Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy(ESAWAAPT) | November 22, 2020 | March 31, 2023 |
NCT05304455 | Completed | N/A | Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection | April 1, 2022 | May 31, 2023 |
NCT00839163 | Completed | Phase 2 | Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT) | March 2004 | October 2005 |
NCT00839657 | Completed | Phase 3 | Clarification of Optimal Anticoagulation Through Genetics | September 2009 | November 2013 |
NCT00878826 | Completed | Phase 2/Phase 3 | Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy. | May 2009 | October 2014 |
NCT00986154 | Completed | Phase 3 | Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). | October 2009 | April 2013 |
NCT01086215 | Completed | Registry of AngioJet Use in the Peripheral Vascular System | January 2010 | September 2013 | |
NCT01145859 | Completed | Phase 1 | Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects | November 2010 | July 2015 |
NCT01240330 | Completed | N/A | Vasculaire Compression System Increases Flow Velocity in the Femoral Vein | August 2010 | September 2010 |
NCT01297348 | Completed | Study Of Lybrel In Relation To Venous Thromboembolism | July 2007 | April 2012 | |
NCT01317160 | Completed | N/A | Compression Treatment Effects on Complications and Healing of Achilles Tendon Rupture | March 2011 | September 2018 |
NCT01354704 | Completed | Phase 4 | Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin | March 2011 | October 2015 |
NCT01482273 | Completed | N/A | Ultrasound-enhanced Thrombolysis Versus Standard Catheter Directed Thrombolysis for Ilio-femoral Deep Vein Thrombosis | November 2011 | November 2014 |
NCT01495429 | Completed | Phase 3 | Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurological Intensive Care | January 2012 | July 2015 |
NCT01507051 | Completed | Phase 1 | Switching Study From Warfarin to Rivaroxaban | November 2008 | November 2009 |
NCT01608906 | Completed | N/A | Using Intravenous Heparin Versus Standard of Care Subcutaneous Heparin to Prevent Clots After Surgery | May 2007 | May 2014 |
NCT01619007 | Completed | Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy | June 2012 | July 2015 | |
NCT02877251 | Not yet recruiting | Mexican Multidisciplinary Registry of Patients With Venous Thromboembolic Disease | December 2023 | December 2024 | |
NCT04649489 | Recruiting | A Study to Evaluate Efficacy and Safety of Hepatic Resection for Liver Cancer With PVTT, HVTT or IVCTT After Initial Ate/Bev | April 19, 2021 | March 31, 2028 | |
NCT04156230 | Recruiting | Phase 2 | Diagnostic Validity of [18F]GP1 PET for Diagnosing Acute Deep Vein Thrombosis | January 13, 2020 | December 31, 2025 |
NCT04889326 | Recruiting | Collection of the Thrombo-VaxCov Cohort | April 2, 2021 | May 2023 | |
NCT02810704 | Recruiting | Phase 4 | Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement | December 2016 | July 2025 |
NCT02650453 | Recruiting | Ongoing Registry of Deep Venous Reconstructions | September 2009 | September 2029 | |
NCT01042067 | Suspended | Safer Warfarin Treatment | January 2010 | ||
NCT01406795 | Terminated | N/A | The GORE Viabahn Endoprosthesis for the Treatment of Venous Occlusions and Stenoses | December 2010 | December 2014 |
NCT02649023 | Terminated | Deep Venous Thrombosis After Hepatobiliopancreatic Surgery | January 2016 | April 2018 | |
NCT00521885 | Terminated | N/A | Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients | September 2007 | September 2009 |
NCT00539942 | Terminated | Phase 3 | Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy | April 2007 | June 2010 |
NCT01051297 | Terminated | Obstructive Sleep Apnea and Venous Thromboembolism | March 2009 | May 2015 | |
NCT00186745 | Terminated | N/A | Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure | March 2005 | February 2016 |
NCT00872079 | Terminated | N/A | Personalized Warfarin Dosing by Genomics and Computational Intelligence | September 2008 | September 2011 |
NCT02506985 | Terminated | Phase 4 | XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis | July 2015 | June 29, 2016 |
NCT01717495 | Unknown status | Thromboembolic Complications After Pacemaker or Implantable Cardioverter-Defibrillator Procedures | April 2013 | April 2016 | |
NCT04732299 | Unknown status | Staging and Prognosis of Deep Venous Thrombosis of Lower Extremities | December 1, 2021 | February 1, 2024 | |
NCT03773939 | Unknown status | Risk Prediction of Venous Thromboembolism in Critically Ill | March 27, 2015 | October 1, 2021 | |
NCT02597218 | Unknown status | Incidence of Venous Thromboembolic Disease and Portal Vein Thrombosis After Hepatectomy. A Cohort Study. | October 2015 | February 2020 | |
NCT02697123 | Unknown status | Prospective Assessment of the Deep Vein Thrombosis (DVT) in Hospitalized Obstetrics Patients | January 2016 | January 2024 | |
NCT04036656 | Unknown status | Phase 1 | Phase I Study of Direct Coagulation Factor Xa Inhibitor SYHA136 Tablets in Chinese Healthy Volunteers | August 2019 | May 2020 |
NCT02752984 | Unknown status | Study on the Incidence of Early Deep Vein Thrombosis After Peripherally Inserted Central Catheter Insertion | April 2016 | June 2018 | |
NCT02062021 | Unknown status | Understanding the Role of Autoimmune Disorders on the Initial Presentation of Cardiovascular Disease | January 2014 | June 2015 | |
NCT04967573 | Unknown status | Phase 3 | Prophylactic vs Therapeutic Anticoagulation in Symptomatic Isolated Distal Deep Vein Thrombosis | August 1, 2021 | December 31, 2023 |
NCT02238444 | Unknown status | Phase 4 | Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy | September 1, 2014 | September 30, 2019 |
NCT03001544 | Unknown status | Phase 1 | Study of Safety and Biomarker Efficacy of TS23 in Healthy Volunteer | July 2015 | June 2017 |
NCT01252420 | Unknown status | Phase 4 | Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis | November 2010 | November 2014 |
NCT02264743 | Unknown status | Phase 4 | Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy | November 2013 | November 2015 |
NCT02264964 | Unknown status | N/A | Duration and Adverse Events of Non-cuffed Catheter in Patients With Hemodialysis | January 2015 | December 2017 |
NCT01382550 | Unknown status | Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin. | March 1993 | ||
NCT01413464 | Unknown status | The Risk of Venous Clotting in Patients After Renal Transplant | March 2011 | September 2013 | |
NCT02268630 | Unknown status | Long Term Outcomes of Venous Thromboembolism | January 2014 | October 2023 | |
NCT00162435 | Unknown status | N/A | Genetic Determinants of Warfarin Anticoagulation Effect | August 2002 | December 2020 |
NCT02343198 | Unknown status | N/A | The Use of NMES as a Home-based Therapy Following Total Knee Arthroplasty | August 2014 | December 2015 |
NCT02414802 | Unknown status | N/A | Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis | December 2014 | December 2017 |
NCT02767232 | Withdrawn | Phase 3 | Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial | July 2018 | June 2023 |
NCT01164540 | Withdrawn | Phase 3 | Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis | February 2011 | March 2013 |
NCT00808626 | Withdrawn | Phase 1/Phase 2 | Phase II Investigation of 99mTc-rBitistatin for Imaging Venous Thrombosis | December 2008 | March 2017 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0004936
- MeSH unique ID (MeSH (Medical Subject Headings))
- D020246